Literature DB >> 6970731

Structure-activity relationships in the development of hypoxic cell radiosensitizers. III. Effects of basic substituents in nitroimidazole sidechains.

G E Adams, I Ahmed, E D Clarke, P O'Neill, J Parrick, I J Stratford, R G Wallace, P Wardman, M E Watts.   

Abstract

The effects of substituting 2-nitroimidazoles with groups carrying basic functions were studied. Prototropic, redox, lipophilicity and protein-binding properties were compared with the efficiency in radiosensitizing hypoxic Chinese hamster V79-379A cells in vitro and the cytotoxicities of the compounds after chronic aerobic exposure. Seventeen compounds were (2-nitro-1-imidazolyl)alkylamines in which the effects of changes in the terminating base and of alkyl chain length were investigated. About an order of magnitude increase in sensitization efficiency could be observed in some compounds without any increase in the aerobic cytotoxicity compared to simple, uncharged 2-nitroimidazoles such as misonidazole. The behaviour of five hydrazones was similar to that of uncharged analogues. The methiodide quaternary salts of two of the (2-nitro-1-imidazolyl)alkylamines showed that quaternization considerably reduced sensitization efficiency. (Nitro-1-imidazolyl)alkylamines appear worthy of further investigation as hypoxic cell radiosensitizers in vivo.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6970731     DOI: 10.1080/09553008014551451

Source DB:  PubMed          Journal:  Int J Radiat Biol Relat Stud Phys Chem Med        ISSN: 0020-7616


  5 in total

Review 1.  Nitroimidazoles as hypoxic cell radiosensitizers and hypoxia probes: misonidazole, myths and mistakes.

Authors:  Peter Wardman
Journal:  Br J Radiol       Date:  2018-03-20       Impact factor: 3.039

2.  Radiation sensitization and chemopotentiation: RSU 1069, a compound more efficient than misonidazole in vitro and in vivo.

Authors:  G E Adams; I Ahmed; P W Sheldon; I J Stratford
Journal:  Br J Cancer       Date:  1984-05       Impact factor: 7.640

3.  DNA-targeted 2-nitroimidazoles: in vitro and in vivo studies.

Authors:  D S Cowan; J F Matejovic; R A McClelland; A M Rauth
Journal:  Br J Cancer       Date:  1994-12       Impact factor: 7.640

4.  Structure/activity relationships for the enhancement by electron-affinic drugs of the anti-tumour effect of CCNU.

Authors:  P Workman; P R Twentyman
Journal:  Br J Cancer       Date:  1982-08       Impact factor: 7.640

5.  Synthesis and Biological Evaluation of Iodoglucoazomycin (I-GAZ), an Azomycin-Glucose Adduct with Putative Applications in Diagnostic Imaging and Radiotherapy of Hypoxic Tumors.

Authors:  Piyush Kumar; Hassan R H Elsaidi; Bohdarianna Zorniak; Evelyn Laurens; Jennifer Yang; Veena Bacchu; Monica Wang; Leonard I Wiebe
Journal:  ChemMedChem       Date:  2016-07-05       Impact factor: 3.466

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.